Editorial Board: Journal of Neurosurgery

Editor-in Chief
James Rutka

Associate Editor
Fred G. Barker II

Co-Chairs
Justin F. Fraser (6/18 – 5/24)
Rose Du (5/19 – 5/24)
Judy Huang (5/19 – 5/24)
Anthony M. Kaufmann (5/19 – 5/24)
Gabriel Zada (5/19 – 5/24)

Editorial Board
Manish Aghi (5/20 – 5/25)
Andrew Carlson (5/20 – 5/25)
Elizabeth B. Claus (5/20 – 5/25)
William Mack (5/20 – 5/25)
Daniel M. Prevedello (5/20 – 5/25)
Bernard R. Bendok (5/21 – 5/26)
Kate Drummond (5/21 – 5/26)
Constantinos Hadjipanayis (5/21 – 5/26)
David Hasan (5/21 – 5/26)
Peter Kan (5/21 – 5/26)
Nader Sanai (5/21 – 5/26)
Alon Mogilner (5/22 – 5/27)

Dario J. Englot (5/22 – 5/27)
Ian F. Parney (5/22 – 5/27)
Juan Fernandez-Miranda (5/22 – 5/27)
Michael Lim (5/22 – 5/27)
Phil Taussky (5/22 – 5/27)
Stacey Quintero Wolfe (5/22 – 5/27)
Sunit Das (5/22 – 5/27)
Adam S. Arthur (5/23 – 5/28)
Kaisorn Chaichana (5/23 – 5/28)
Pablo F. Recinos (5/23 – 5/28)
Robert M. Starke (5/23 – 5/28)
Stavropoula Tjoumakaris (5/23 – 5/28)
Thomas J. Wilson (5/23 – 5/28)

 

Editorial Boards members are selected by a vote undertaken by standing members of each journal’s Editorial Board. Members serve approximately 5 years, advancing to the position of Co-Chair in their final year. Editorial Board members usually review 100+ manuscripts per year; this number increases to nearly 300 manuscripts during their final year as Co-Chair.


Justin F. Fraser

Dr. Fraser graduated from Princeton University with a degree from the Woodrow Wilson School of Public and International Affairs. His Princeton thesis discussed the American healthcare system, focusing upon the effect of managed care on the physician-patient relationship. He obtained his medical degree from the Weill Medical College of Cornell University. He completed residency in neurological surgery at Weill Cornell Medical College, where he also completed a fellowship in endovascular neurosurgery/interventional neuroradiology. He is currently Associate Professor and Director of Cerebrovascular Surgery in the Department of Neurological Surgery at University of Kentucky, where he specializes in cerebrovascular, endovascular, skull base, and endoscopic transsphenoidal surgery. As Surgical Director of the University of Kentucky Comprehensive Stroke Center, he focuses on treating stroke, carotid stenosis, intracranial aneurysms, arteriovenous malformation, pituitary tumors, and other skull base tumors. His academic research focuses upon the further advancement of the neuroprotective therapies for acute ischemic stroke. He has been Principal Investigator on several investigator-initiated clinical studies (eg. SAVER-I, STABILISER, MAVARIC), as well as a site-PI for multiple industry-led clinical trials. In the UK Center for Advanced Translational Stroke Science, Dr. Fraser leads a research team that has built an ongoing tissue bank for evaluating molecular and cellular changes in acute stroke patients.

Dr. Fraser was elected to the Editorial Board of Journal of Neurosurgery in 2018.

 

Rose Du, MD

Rose Du, MD, PhD, is Professor of Neurosurgery and Director of Cerebrovascular Surgery at Brigham and Women’s Hospital/Harvard Medical School. She received her BA (summa cum laude) in physics from Harvard University. She subsequently entered Harvard Medical School’s MD/PhD program and received her PhD in physics from the Massachusetts Institute of Technology, where she studied protein folding. She completed her internship and residency at the University of California at San Francisco, after which she undertook a cerebrovascular fellowship with Dr. Arthur Day at the Brigham and Women’s Hospital. She subsequently joined the faculty at the Brigham and Women’s Hospital.

Dr. Du’s research interests include the genetics of stroke and cerebral aneurysms, as well as other cerebrovascular diseases. Her research has been funded by the National Institutes of Health, as well as by several private foundations. She has more than 150 scientific publications and currently serves on the editorial boards of Neurosurgery, Stroke, and Translational Stroke Research. Dr. Du was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Judy Huang, MD

Dr. Judy Huang is Professor and Vice Chair of Neurosurgery at the Johns Hopkins University School of Medicine. In addition, she serves as Director of the Neurosurgery Residency Program and Director of the Cerebrovascular Surgery Fellowship.

After graduating magna cum laude from Brown University, she received her MD from the Columbia University College of Physicians & Surgeons. Her neurosurgery residency training was completed at the Neurological Institute of New York.

Dr. Huang’s clinical and research interests are devoted primarily to arteriovenous malformations, aneurysms, and ischemic and hemorrhagic stroke. She has won awards for excellence in teaching and clinical care. She has authored numerous peer-reviewed publications and book chapters and serves on the editorial board of Neurosurgery. Dr. Huang is often invited to lecture at international and national conferences. She has served on several committees of the SNS, AANS, and CNS, and as Secretary of the Neurosurgical Society of America, and is an ABNS Examiner. Dr. Huang was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Anthony M. Kaufmann, MD

Dr. Kaufmann received his MD, BSc (Medicine), and MSc (Surgery) from the University of Manitoba, where he also completed his neurosurgery residency. He then joined the Department of Neurological Surgery at the University of Pittsburgh Medical Center (1994–1997) before returning to Canada, at the University of Calgary (1997–2000) and then the University of Manitoba (2001–present). In addition to specialization in cerebrovascular and cranial base microneurosurgery, he is Director of both the Winnipeg Centres for Cranial Nerve Disorders and GammaKnife Surgery, as a well as Supervisor of the Intra-Operative Monitoring Program.

Dr. Kaufmann is board certified by both the Royal College of Physicians and Surgeons of Canada (1994) and the American Board of Neurosurgical Surgeons (2017). He served on the Neurosurgery Examination Committee for the Royal College of Physicians and Surgeons of Canada (2013–2017). Dr. Kaufmann was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Gabriel Zada, MD

Dr. Gabriel Zada is an Associate Professor of Neurosurgery, Otolaryngology, and Internal Medicine at the Keck School of Medicine of USC. He attended UC Berkeley for his undergraduate studies and medical school at UC San Francisco. He then went on to complete his residency at USC, under the mentorship of Dr. Martin Weiss and Dr. Steven Giannotta. He completed a fellowship in endoscopic pituitary and skull base surgery at Brigham and Women’s Hospital with Dr. Edward Laws. He joined the USC faculty in 2011 and currently serves as Director of the USC Endoscopic Skull Base Surgery Program, Co-Director of the USC Pituitary Center, and Co-Director of the USC Stereotactic Radiosurgery Program. He is the Associate Program Director of the USC Neurosurgery Residency Program.

Dr. Zada has a keen clinical and academic interest in brain and skull base tumor surgery and has published more than 150 peer-reviewed articles on various topics, mostly relating to brain/pituitary tumors, skull base surgery, neuroendoscopy, simulation-based education, and stereotactic radiosurgery. He coauthored and edited the textbook entitled The Atlas of Sellar and Parasellar Lesions. He is an independent NIH-funded principal investigator, whose research laboratory at the USC Zilkha Neurogenetic Institute focuses on the genomics and epigenetics of pituitary tumors and meningiomas. Dr. Zada also serves on the editorial board of Neurosurgery and the Journal of Neuro-Oncology. Dr. Zada was elected to the editorial board of the Journal of Neurosurgery in 2019.

 

Manish Aghi

Manish Aghi, MD, PhD, is a Professor and Vice Chair of Neurosurgery at the University of California, San Francisco (UCSF). He attended Stanford University for his undergraduate studies and completed MD-PhD degrees at Harvard University. He then went on to complete his residency at Massachusetts General Hospital. He joined the UCSF faculty in 2008 and currently serves as Director of the Center for Minimally Invasive Skull Base Surgery, Head of the Education Division and Clerkship Director in the Department of Neurosurgery, and a Principal Investigator in the Brain Tumor Research Center. Dr. Aghi runs a basic science laboratory studying the brain tumor microenvironment that has been continuously NIH funded since joining the UCSF faculty. He has published nearly 200 peer-reviewed basic science and clinical articles focused on brain tumors. He was elected to the American Academy of Neurological Surgery in 2016 and served as Chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) Joint Section on Tumors from 2018 to 2020. Dr. Aghi also serves on the editorial board of Neurosurgery and the Journal of Neuro-Oncology. Dr. Aghi was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Andrew Carlson

Andrew Carlson, MD, MS-CR, is a faculty neurosurgeon at the University of New Mexico. Born in Los Alamos, New Mexico, Dr. Carlson trained at the University of New Mexico and did fellowships in endovascular neurosurgery at the University of Illinois–Chicago and skull base/vascular at the University of South Florida, ultimately returning to practice in the only tertiary care center for neurosurgery in New Mexico. He is the Director of Research in Neurosurgery and Director of Cerebrovascular and Neurointerventional Surgery. He is the Co-Director of the New Mexico Spreading Depolarization Consortium. Nationally, Dr. Carlson is an active reviewer for the Joint Guidelines Review Committee and also serves on the multispecialty American Board of Psychiatry and Neurology (ABPN) Neurocritical Care Examination Writing Committee. He has published many peer-reviewed articles and is centrally involved in multiple clinical trials. He is NIH funded for clinical research focused on secondary brain injury and spreading depolarizations. Dr. Carlson was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Elizabeth B. Claus

Elizabeth B. Claus, MD, PhD, is a Professor and Director of Medical Research in the Yale University School of Public Health as well as Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston, Massachusetts. She received her undergraduate degree from Wellesley College, a master’s degree in mathematics from the University of Virginia, and her MD-PhD from Yale University. Dr. Claus trained as a neurosurgeon at Yale–New Haven Hospital and completed a fellowship in neurosurgical oncology at Brigham and Women’s Hospital. She is a member of the Council of Medical Advisors for the American Brain Tumor Association (ABTA) as well as the Central Brain Tumor Registry of the United States (CBTRUS). Dr. Claus’ research is focused on cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall Principal Investigator of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In partnership with national patient brain tumor organizations including the ABTA, the Acoustic Neuroma Association (ANA), and the National Brain Tumor Society (NBTS), Dr. Claus is working to develop cost- and time-efficient web-based recruitment strategies to be used in the study of brain tumors, including the Yale Acoustic Neuroma Study and the International Low Grade Glioma Registry. Dr. Claus was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

William Mack

William Mack, MD, is a Professor of Neurosurgery, Vice Chair of Academic Affairs, and a faculty member of the Neuroscience Graduate Program at University of Southern California. His area of clinical focus is endovascular and open surgical management of patients with cerebrovascular disease. Dr. Mack received his bachelor’s degree with honors from Cornell University. He then attended Columbia University, College of Physicians and Surgeons, where he graduated from medical school and completed neurosurgical residency training. Following residency, Dr. Mack completed an Interventional Neuroradiology fellowship at UCLA. Dr. Mack is the Principal Investigator and Director of the Cerebrovascular Laboratory in the Zilkha Neurogenetic Institute. His overarching academic goal is to examine the effects of inflammation/air pollution in experimental models of cerebrovascular disease. Dr. Mack is the Principal Investigator on active NIH (NINDS, NIA, and NIEHS) grants. He also serves as an Associate Editor of the Journal of Neurointerventional Surgery and an Editorial Board member for World Neurosurgery. Dr. Mack serves on the Board of Directors of the Society of Neurointerventional Surgery and Executive Committee of the Joint Cerebrovascular Section of the Congress of Neurological Surgeons/American Association of Neurological Surgeons. Dr. Mack was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Daniel M. Prevedello

Daniel M. Prevedello, MD, is currently Professor of Neurosurgery and Otolaryngology–Head and Neck Surgery, Co-Director of the Comprehensive Skull Base and Pituitary Surgery Center and Director of the Minimally Invasive Cranial Surgery Program at The Ohio State University, Wexner Medical Center and Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Dr. Prevedello is also Co-Director of the Anatomy Laboratory Toward Visuospatial Surgical Innovations in Otolaryngology and Neurosurgery (ALT-VISION) at The Ohio State University. Dr. Prevedello attended medical school at the Universidade Federal do Parana in Curitiba, Brazil, where he also completed his neurological surgery residency at the Hospital Nossa Senhora das Graças. He completed a fellowship in neuroendocrine and pituitary surgery at the University of Virginia and another in skull base and cerebrovascular surgery at the University of Pittsburgh. In 2008 Dr. Prevedello joined the Faculty at the University of Pittsburgh as Assistant Professor and was named Director of the Skull Base Surgery Training Program. In 2010 he moved to The Ohio State University, where he became Associated Professor in 2012. As the Director of the Minimally Invasive Cranial Surgery Program and Co-Director of the Comprehensive Skull Base and Pituitary Surgery, Dr. Prevedello was promoted to Professor with Tenure of The Ohio State University in 2017. Dr. Prevedello has a particular clinical and academic interest in brain and skull base tumor surgery and has published more than 250 peer-reviewed articles on various topics mostly related to brain and skull base tumors, skull base reconstruction, neuroendoscopy, and novel techniques and technologies. Dr. Prevedello also serves on the editorial boards of Operative Neurosurgery, World Neurosurgery, and Frontiers in Neurology/Oncology. Dr. Prevedello was elected to the editorial board of the Journal of Neurosurgery in 2020.

 

Bernard R. Bendok

Dr. Bernard R. Bendok is the Chair of the Department of Neurosurgery at Mayo Clinic in Arizona and the William J. and Charles H. Mayo Professor of Neurosurgery, Radiology, and Otolaryngology in the Mayo Clinic Alix School of Medicine. He also serves as the neurosurgery residency director at Mayo Clinic in Arizona and the Director of the Cerebrovascular Endovascular and Skull Base Fellowship. His practice is focused on cerebrovascular diseases, skull base diseases, and brain tumors. His research is focused on simulation science, device innovation, and clinical trials. Dr. Bendok was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Kate Drummond

Dr. Kate Drummond is the Director of Neurosurgery at Royal Melbourne Hospital and Head of CNS Tumors at the VCCC Parkville Precinct. Her research and clinical interests are in the biology and management of brain tumors. She has published over 140 peer-reviewed articles and received more than $15 million in research funding. She is Co-Editor-in-Chief of the Journal of Clinical Neuroscience and immediate past Chief Examiner in Neurosurgery for the Royal Australasian College of Surgeons. She is the Chair of Pangea Global Health Education, a for-impact organization specializing in health education in low-resource settings. In 2019, she was awarded Member of the Order of Australia (AM) for services to medicine, particularly in neuro-oncology. Dr. Drummond was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Constantinos Hadjipanayis

Dr. Constantinos Hadjipanayis is the L. Dade Lunsford Professor of Neurological Surgery at the University of Pittsburgh Medical Center (UPMC). He serves as the Executive Vice-Chairman for the Dept. of Neurological Surgery and is the Director for the Center of Image-Guided Neurosurgery. Dr. Hadjipanayis is the Co-Director of the newly formed UPMC Hillman Brain Tumor Center and oversees the Brain Tumor Nanotechnology Laboratory at the Hillman Cancer Center where he studies novel therapeutics targeting brain tumors. His graduate work at the University of Pittsburgh, during his neurosurgery residency, focused on viral gene therapy of brain cancer. He helped lead the development of 5-ALA (Gleolan) and fluorescence-guided surgery (FGS) for malignant brain tumors in the US that resulted in FDA approval in 2017. Dr. Hadjipanayis was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

David Hasan

Dr. David Hasan is currently a Professor of Neurosurgery, Otolaryngology, and Biomedical Engineering. He completed his medical school training at Texas Tech University with AOA distinction, followed by residency training at the University of Iowa. During his residency he won the prestigious Dandy Walker followship award and spent his 5th year of residency training with Dr. Almefty in skull base surgery. He then went on to finish several fellowships, including diagnostic angiography with Lee Jessen, endovascular with Robert Rosenwasser, and open cerebrovascular with Juha Hernesniemi.

Dr. Hasan is a scientist-neurosurgeon with continuous NIH funding for the last 10 years and currently holds three R01s. He also serves as an assistant editor for Stroke, associate editor for Neurosurgery, and served on several NIH study section review committees. He has authored over 250 peer-reviewed PubMed publications. Dr. Hasan was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Peter Kan

Dr. Peter Kan is the Professor and Robert L. Moody Sr. Chair of the Department of Neurosurgery at the University of Texas Medical Branch. He pursued neurosurgical training and a Master of Public Health at the University of Utah. He then went on to an endovascular fellowship at the University at Buffalo. Upon the completion of his fellowship, he joined the faculty at the University of South Florida and was subsequently recruited to Baylor College of Medicine as the Director of Cerebrovascular Surgery. His research interests include novel neuroendovascular devices, intravascular imaging, and intra-arterial cell-based therapy for malignant brain tumors. Dr. Kan was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Nader Sanai

Dr. Nader Sanai is the J. N. Harber Professor of Neurological Surgery at the Barrow Neurological Institute (BNI). He completed medical school and residency at UCSF, followed by a skull-base surgery fellowship at BNI. As Director of Neurosurgical Oncology, his practice is devoted to patients with benign and malignant brain tumors, particularly those in high-risk areas. He was elected to the American Academy of Neurological Surgeons in 2016 and, in 2018, he founded the Ivy Brain Tumor Center, a nonprofit, early-phase drug development program for brain cancer. His NIH-funded laboratory and clinical research efforts have led to over 150 peer-reviewed publications and 100 national and international lectures in neuro-oncology. Dr. Sanai was elected to the Editorial Board of the Journal of Neurosurgery in 2021.

 

Alon MogilnerAlon Mogilner

Dr. Mogilner is an Associate Professor of Neurosurgery and Anesthesiology at NYU Grossman School of Medicine and the Director of the Center for Neuromodulation at NYU Langone Health. He received his MD and PhD degrees in neuroscience at the NYU School of Medicine and completed his residency in neurosurgery and fellowship in Functional Neurosurgery at NYU Medical Center. He is past president of the AANS/CNS Section on Pain and served as a board member of the American Society for Stereotactic and Functional Neurosurgery for 8 years. He specializes in the use of neuromodulation and lesioning techniques, including deep brain stimulation and focused ultrasound. Dr. Mogilner was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Dario J. EnglotDario J. Englot

Dario J. Englot, MD, PhD, is a tenured Associate Professor of Neurological Surgery, Neurology, Radiology, Electrical Engineering, and Biomedical Engineering at Vanderbilt University. He is also Director of Functional Neurosurgery and Surgical Director of Epilepsy at Vanderbilt University Medical Center, and director of a CAST-accredited fellowship in Functional Neurosurgery. He received his MD and PhD degrees from Yale University and completed neurosurgical residency at the University of California, San Francisco, and his functional neurosurgery fellowship at Vanderbilt University. Dr. Englot leads an active translational research laboratory integrating human neuroimaging and electrophysiology techniques to study brain networks in neurological diseases and normal brain states. He serves on the board of the American Society for Stereotactic and Functional Neurosurgery and he is chair of the Surgical Therapies Commission in the International League Against Epilepsy. He is also a Fellow of the American Epilepsy Society and serves on the editorial boards of Epilepsy Currents and Epilepsy & Behavior. Dr. Englot was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Ian F. ParneyIan F. Parney

Dr. Ian F. Parney is Professor and Vice-Chair of the Department of Neurological Surgery, and Neurosurgical Oncology Fellowship Program Director at the Mayo Clinic in Rochester, Minnesota. Born and raised in Calgary, Alberta, Canada, he attended college at McGill University. After receiving his MD and PhD degrees and completing his neurosurgical residency at the University of Alberta, Dr. Parney completed neuro-oncology training at the University of California, San Francisco, with Dr. Mitch Berger. His clinical and research interests focus on brain tumor surgery and immunotherapy. He is currently the Co-Director of the National Coordination Center for the Glioblastoma Therapeutics Network, an NCI-sponsored cooperative group. Dr. Parney was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Juan Fernandez-Miranda

Dr. Juan Fernandez-Miranda is Professor of Neurosurgery and Chief of Skull Base and Pituitary Surgery at Stanford University Medical Center. He completed neurosurgery residency at La Paz University Hospital in Madrid, Spain. Upon completion of his residency, he was awarded the Sanitas Prize to the best medical postgraduate trainee in the country. From 2005 to 2007, he underwent research fellowship training in microsurgical neuroanatomy at University of Florida under legendary neurosurgeon Albert L. Rhoton Jr. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at University of Virginia and endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). In 2018, after a 10-year tenure at UPMC, Dr. Fernandez-Miranda was recruited to lead the Stanford Skull Base and Pituitary Center and the Stanford Neurosurgical Training and Innovation Center. Dr. Fernandez-Miranda has authored more than 200 peer-reviewed publications with multiple innovative contributions to the fields of endoscopic endonasal skull base and pituitary surgeries, microsurgical neuroanatomy, white matter dissection and tractography, surgical approaches, and techniques. He is co-founder and vice-president of the International Rhoton Society and executive member of the Board of Directors of The Neurosurgical Atlas. Dr. Fernandez-Miranda serves on the editorial boards of Operative Neurosurgery and Journal of Neurological Surgery-Skull Base. Dr. Fernandez-Miranda was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Michael LimMichael Lim

Dr. Michael Lim is Professor and Chair of Neurosurgery at Stanford University. Dr. Lim obtained his MD degree from The Johns Hopkins University School of Medicine. He then completed his residency in Neurosurgery at Stanford University Hospital. Dr. Lim’s surgical interest is brain tumors and trigeminal neuralgia.

Dr. Lim’s research interest is developing immune-based therapies against brain tumors. In addition to understanding the mechanisms of immune evasion by primary brain tumors, findings from his laboratory are directed toward translation to novel therapies against brain tumors. He also serves as the principal investigator of several large brain tumor immunotherapy clinical trials based on findings from his laboratory. Dr. Lim was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Phil TausskyPhil Taussky

Dr. Phil Taussky serves as the Co-Director of the Brain Aneurysm Institute and Surgical Co-Director of the Comprehensive Stroke Center at Beth Israel Deaconess Medical Center in Boston. After receiving his MD degree at the University of Basel, Switzerland, Dr. Taussky completed a neurosurgery residency at the Kantonsspital Aarau, the largest county hospital in Switzerland, which is known for its busy neurosurgery service and its strong cerebrovascular and trauma service. Dr. Taussky then completed a skull base/cerebrovascular fellowship at the University of Utah and an endovascular fellowship at the Mayo Clinic. He was then recruited to the University of Utah where he served as section Chief of Neurovascular Surgery until 2022. Dr. Taussky’s practice is focused on the surgical and endovascular treatment of cerebrovascular disorders of the brain and spinal cord. He has a particular interest in the treatment of intracranial aneurysms and arteriovenous malformations of the brain and spinal cord using novel techniques and devices and a secondary interest in the treatment of skull base tumors. His research interests include novel endovascular devices, management of acute stroke, and complication analysis and prevention. Dr. Taussky was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Stacey Quintero WolfeStacey Quintero Wolfe

Stacey Quintero Wolfe, MD, FAANS, is a Professor of Neurological Surgery and Radiology at Wake Forest School of Medicine. She trained in Neuroendovascular and Cerebrovascular/Skull Base Surgery at the University of Miami and served as Lieutenant Commander in the U.S. Navy before joining Wake Forest School of Medicine, where she is Residency Program Director and Director of Neurointerventional Surgery. Dr. Wolfe is site co-PI of NINDS StrokeNet and has a translational lab investigating neuroinflammation and genomics surrounding hemorrhagic stroke. Dr. Wolfe serves on the AANS Board of Directors and the SNS Executive Council. She has served as Chair of Women in Neurosurgery, Young Neurosurgeons Committee, and the Joint Guidelines Committee. Dr. Wolfe was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Sunit DasSunit Das

Sunit Das is an Associate Professor of Neurosurgery at the University of Toronto and currently serves as the Provincial Lead for CNS Oncology at Cancer Care Ontario. He studied English Literature at the University of Michigan and Philosophy at Harvard University before completing medical school at Northwestern University and doctoral studies in Neurobiology at the National Institutes of Health. Dr. Das’s clinical practice is focused on the care of patients with benign and malignant brain tumors. His laboratory focuses on the molecular and genetic mechanisms that regulate tumor evolution and treatment resistance in glioblastoma. Dr. Das was elected to the Editorial Board of the Journal of Neurosurgery in 2022.

 

Adam S. ArthurAdam S. Arthur

Dr. Adam S. Arthur is the James T. Robertson Endowed Professor and Chair of the Department of Neurosurgery at the University of Tennessee Health Sciences Center. He grew up in a small college town in the Shenandoah Valley, Virginia, and attended the University of Virginia. After college, he worked in the University of Virginia Department of Neurosurgery, where he did research on cerebral vasospasm. He continued this research throughout medical school, obtaining his medical degree from the University of Virginia in 1998. He did his internship and residency at the University of Utah. While in Utah, he also completed his Master of Public Health degree with a focus on clinical trial methodology, graduating summa cum laude in 2002. After finishing his residency in neurosurgery, he went to the Semmes Murphey Clinic and the University of Tennessee Health Sciences Center to complete a fellowship in endovascular and open cerebrovascular neurosurgery.

Dr. Arthur stayed on as faculty after fellowship and took over leadership of the cerebrovascular group. In the process, he became one of the first neurosurgeons in the country to develop a busy practice in both open cerebrovascular surgery and endovascular neurosurgery. He has a strong interest in managing neurovascular disease in both healthy and very sick patients. Semmes-Murphey has grown into one of the busiest cerebrovascular centers in the United States.

At present, Dr. Arthur is actively engaged in several areas of research to improve the treatment of patients with cerebrovascular diseases. Notable among these is WEB-IT, the first PMA trial to result in FDA approval of a device to go inside a cerebral aneurysm and STEM, the first randomized controlled trial to evaluate embolization for the treatment of chronic subdural hemorrhage. Dr. Arthur is currently serving as international principal investigator for seven other multicenter clinical trials investigating the treatment of aneurysms, ischemic stroke, and intracranial hemorrhage. He has played a significant role in national and international education, recently completing a term as President of the Society for Neurointerventional Surgery and now serving as Chair of the AANS/CNS Joint Cerebrovascular Section and Chair of the Neurosurgery Research and Education Foundation. Dr. Arthur was elected to the Editorial Board of the Journal of Neurosurgery in 2023.

 

Kaisorn ChaichanaKaisorn Chaichana

Dr. Kaisorn Chaichana is a board-certified, fellowship-trained neurosurgeon in skull base and brain tumor surgery who offers the most up-to-date and comprehensive treatments for adult patients with both benign and malignant brain tumors. He specializes in the treatment of patients with primary brain tumors such as gliomas, meningiomas, and pituitary tumors, as well as skull base and metastatic brain tumors. He practices the most advanced treatments in minimally invasive surgery, endoscopic surgery, and awake brain mapping. He is the director of brain tumor surgery at Mayo Clinic in Jacksonville, Florida, as well as the neurosurgery residency director. He has published more than 200 peer reviewed papers and edited four textbooks. Dr Chaichana was elected to the Editorial Board of the Journal of Neurosurgery in 2023.

 

Pablo F. RecinosPablo F. Recinos

Dr. Pablo Recinos is currently an Associate Professor of Neurological Surgery and Otolaryngology-Head and Neck Surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He completed his undergrade studies at the University of Iowa, medical school and neurosurgery residency at Johns Hopkins University, and subspecialty training in open skull base surgery at Cleveland Clinic and endoscopic skull base surgery at the University of North Carolina. He joined the Cleveland Clinic faculty in 2014 and currently serves as the Section Head of Skull Base Surgery, Associate Director of the Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, and Co-Director of the Minimally Invasive Cranial Base and Pituitary Surgery Program at Cleveland Clinic.

Dr. Recinos’ clinical practice is devoted to skull base tumor surgery. Academically, he has published more than 125 peer-reviewed articles with a particular focus on benign and malignant skull base tumors, minimally invasive approaches to the orbit, skull base reconstruction techniques, and innovative technologies. He is the Director of the Advanced Endoscopic and Open Skull Base Surgery fellowship at Cleveland Clinic and was previously on the editorial board of World Neurosurgery. Dr. Recinos was elected to the Editorial Board of the Journal of Neurosurgery in 2023.

 

Robert M. StarkeRobert M. Starke

Dr. Robert M. Starke is a tenured member of the Departments of Neurological Surgery, Neuroradiology, Neurosciences, and Pharmacology at the University of Miami Miller School of Medicine. He has a busy clinical practice, performing more than 700 operations each year. He specializes in the treatment of cerebral vascular disease, brain tumor, and skull base surgery including microsurgery, neurointerventional radiology, and radiosurgery.

Previously, he graduated magna cum laude with a BA from Princeton University and distinction in neuroscience. He obtained his medical doctorate from Albert Einstein College of Medicine, graduating with distinction in clinical and translational research. He also obtained a Master of Medical Science degree with distinction in neuroscience research as part of the National Institutes of Health Clinical Research Training Program. He also completed a cerebral vascular research fellowship at Columbia University, which provided him with a wide background in epidemiology and statistics. Dr. Starke attended neurosurgery residency at the University of Virginia. He also completed endovascular neuroradiology fellowships at Thomas Jefferson University and University of Virginia and a cerebral vascular and skull base fellowship at Auckland University Hospital, New Zealand. He is board-certified in neurosurgery and certified by the Committee on Advance Subspecialty Training in Endovascular Therapies.

His laboratory is supported by multiple grants, including more than $3 million from the National Institutes of Health to study aneurysms. His research focuses on cerebral vascular pathophysiology including aneurysm, AVM, ICH, and ischemic stroke models. These avenues allow for the development of novel cellular, medical, radiographic, surgical, and endovascular techniques. He has co-authored more than 700 academic publications. As the Director of Neurovascular Research, he helps run numerous clinical trials for minimally invasive treatment of cerebral vascular disease and brain tumors. Dr. Starke was elected to the Editorial Board of the Journal of Neurosurgery in 2023.

 

Stavropoula TjoumakarisStavropoula Tjoumakaris

Dr. Stavropoula Tjoumakaris is a Professor in Neurological Surgery at Thomas Jefferson University Hospital. She also serves as the Chair of the University Faculty Affairs, Director of the Open Cerebrovascular and Endovascular Fellowship, Associate Director of the Neurosurgery Residency Program, and Director for the Neurosurgery Medical Clerkship. Dr. Tjoumakaris holds the distinction of being the first female dual-trained cerebrovascular and endovascular neurosurgeon in the United States. She is a fellow of the American Association of Neurological Surgeons, American College of Surgeons, and American Heart Association/American Stroke Association. She received her undergraduate degrees in biology, physics, and chemistry from Richard Stockton College in New Jersey, where she graduated summa cum laude and was honored as class salutatorian. Dr. Tjoumakaris attended medical school at Jefferson Medical College, where she graduated with distinction. She was inducted into the Alpha Omega Alpha Honor Society and received numerous awards for academic excellence. Dr. Tjoumakaris subsequently completed her neurosurgical residency at Thomas Jefferson University Hospital, where she also completed a fellowship in endovascular and cerebrovascular neurosurgery. She is an active member of and holds leadership positions in organized neurosurgery and currently serves as the Secretary of the Cerebrovascular Section of the AANS/CNS. She is past Member-at-Large for the Society of Neurointerventional Surgery. She serves as an officer for guidelines for the American Heart Association and Interventional Surgery. Dr. Tjoumakaris has been the recipient of numerous academic, educational, and clinical awards throughout her career, including the Dean’s Award in Excellence in Education, Excellence in Surgical Teaching Award, and Dean’s Award in Faculty Mentoring as well as being recognized for outstanding clinical and basic science research projects at the Pan-Philadelphia annual research meetings. Dr. Tjoumakaris has authored more than 300 peer-reviewed articles in the field of cerebrovascular neurosurgery. She has a particular interest in evolving techniques in the endovascular management of stroke, cerebral aneurysms, arteriovenous malformations, and intra-arterial chemotherapy for retinoblastoma and is currently involved in numerous clinical trials. Dr. Tjoumakaris was elected to the Editorial Board of the Journal of Neurosurgery in 2023.

 

WilsonThomas J. Wilson

Dr. Thomas J. Wilson is a Clinical Associate Professor of Neurosurgery and Co-Director of the Center for Peripheral Nerve Surgery at Stanford University. He completed his medical doctorate at the University of Nebraska Medical Center and then his neurological surgery residency at the University of Michigan, mentored by Dr. Lynda Yang. He then completed a peripheral nerve surgery fellowship at the Mayo Clinic with Dr. Robert Spinner. He also holds a Master of Public Health degree from the Bloomberg School of Public Health at Johns Hopkins University, with certificates in Health Finance and Management and Clinical Trials.

Dr. Wilson's clinical practice focuses on the treatment of patients with the full gamut of peripheral nerve pathologies, including nerve injuries, nerve tumors, nerve pain, entrapment neuropathies, and spasticity. His research focuses on advancing novel diagnostic techniques for these patients, including the application of artificial intelligence approaches and the development of new diagnostic imaging modalities. He is also focused on advancing care for spinal cord injury patients by applying and optimizing nerve transfer strategies and spasticity surgery. Dr. Wilson was elected to the Editorial Board of the Journal of Neurosurgery in 2023.